Holen Sie sich die Stockscreener-App
3.95
0.75%
-0.03
Schlusskurs vom Vortag:
$3.98
Offen:
$3.98
24-Stunden-Volumen:
3,749
Relative Volume:
0.07
Marktkapitalisierung:
$29.29M
Einnahmen:
$7.00M
Nettoeinkommen (Verlust:
$-70.79M
KGV:
-0.4076
EPS:
-9.69
Netto-Cashflow:
$-64.34M
1W Leistung:
-2.95%
1M Leistung:
+1.28%
6M Leistung:
-32.59%
1J Leistung:
-30.34%
1-Tages-Spanne:
$3.925
$4.00
1-Wochen-Bereich:
$3.925
$4.10
52-Wochen-Spanne:
$3.6201
$9.18
Kezar Life Sciences Inc Stock (KZR) Company Profile
Firmenname
Kezar Life Sciences Inc
Sektor
Branche
Telefon
650-822-5600
Adresse
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie KZR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
3.95 | 29.29M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2018-07-16 | Eingeleitet | Jefferies | Buy |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
| 2018-07-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Kezar Life Sciences Inc Aktie (KZR) Neueste Nachrichten
Kezar Life Sciences (NASDAQ:KZR) Upgraded to “Sell” at Wall Street Zen - Defense World
Real time scanner hits for Kezar Life Sciences Inc. explained2025 Price Targets & Smart Money Movement Alerts - Newser
What’s the recovery path for long term holders of Kezar Life Sciences Inc.Trade Exit Summary & Reliable Price Breakout Alerts - Newser
Using Python tools to backtest Kezar Life Sciences Inc. strategiesQuarterly Earnings Summary & Long-Term Safe Investment Ideas - Newser
Why Kezar Life Sciences Inc. is moving todayMarket Trend Report & Verified High Yield Trade Plans - Newser
What earnings revisions data tells us about Kezar Life Sciences Inc.2025 Top Decliners & Risk Controlled Daily Plans - Newser
Kezar Life Sciences Inc. stock trendline breakdown2025 Market Sentiment & AI Forecast Swing Trade Picks - Newser
Using fundamentals and technicals on Kezar Life Sciences Inc.Market Risk Analysis & High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on Kezar Life Sciences Inc.Portfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Is Kezar Life Sciences Inc. stock entering bullish territoryWeekly Loss Report & Real-Time Volume Analysis - Newser
Analyzing net buyer seller activity in Kezar Life Sciences Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
Kezar Life Sciences Inc. stock volume spike explainedTrade Signal Summary & Verified Stock Trade Ideas - Newser
Should you hold or exit Kezar Life Sciences Inc. nowWeekly Market Report & Daily Technical Stock Forecast Reports - Newser
How to track smart money flows in Kezar Life Sciences Inc.2025 Market Overview & Smart Allocation Stock Reports - Newser
Does Kezar Life Sciences Inc. qualify in momentum factor screeningWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
What the charts say about Kezar Life Sciences Inc. todayMarket Risk Analysis & Weekly High Return Opportunities - Newser
Custom watchlist performance reports with Kezar Life Sciences Inc.Chart Signals & Safe Capital Investment Plans - Newser
can technical indicators confirm kezar life sciences inc.’s reversalJuly 2025 Institutional & Verified Short-Term Plans - Newser
Applying Wyckoff theory to Kezar Life Sciences Inc. stock2025 Dividend Review & Consistent Return Strategy Ideas - Newser
what to expect from kezar life sciences inc. in the next 30 daysJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
Can Kezar Life Sciences Inc. hit a new high this monthJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Can Kezar Life Sciences Inc. ride the EV wave2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Can Kezar Life Sciences Inc. maintain its current growth rateJuly 2025 PostEarnings & Long-Term Capital Growth Strategies - خودرو بانک
Is Kezar Life Sciences Inc. likely to announce a buybackJuly 2025 Levels & Fast Moving Market Watchlists - خودرو بانک
What’s the RSI of Kezar Life Sciences Inc. stockJuly 2025 Summary & Community Consensus Trade Alerts - خودرو بانک
Does Kezar Life Sciences Inc. have a sustainable dividendEarnings Risk Report & Accurate Entry/Exit Alerts - خودرو بانک
Is Kezar Life Sciences Inc. exposed to political risk2025 Year in Review & Technical Pattern Based Signals - خودرو بانک
Regression analysis insights on Kezar Life Sciences Inc. performance2025 Market Outlook & High Yield Stock Recommendations - Newser
Technical signs of recovery in Kezar Life Sciences IncMarket Movement Recap & Low Risk Investment Opportunities - Newser
Is Kezar Life Sciences Inc. stock ready for a breakout2025 Buyback Activity & Entry Point Confirmation Alerts - Newser
Exit strategy if you’re trapped in Kezar Life Sciences Inc.Quarterly Earnings Summary & Target Return Focused Stock Picks - Newser
Forecasting Kezar Life Sciences Inc. price range with options dataQuarterly Risk Review & Long-Term Capital Growth Strategies - Newser
Signal strength of Kezar Life Sciences Inc. stock in tech scannersOil Prices & Smart Swing Trading Alerts - Newser
Risk On: Should you avoid Kezar Life Sciences Inc. stock right nowInsider Buying & AI Forecast for Swing Trade Picks - خودرو بانک
Detecting support and resistance levels for Kezar Life Sciences Inc.Weekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser
Is Kezar Life Sciences Inc. a potential multi bagger2025 Momentum Check & Long-Term Growth Portfolio Plans - خودرو بانک
Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):